Background C-reactive protein (CRP) is commonly used to assess systemic inflammation, yet its prognostic value in acute ...
Serum REG3α biomarker improved assessment of ulcerative colitis activity when combined with C reactive protein. Read more.
Zimlovisertib plus tofacitinib showed greater efficacy than tofacitinib alone in reducing Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) in patients with rheumatoid arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results